Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
| ▸ | MMP8 | P22894 | 1/20 | 0.54 |
| ▸ | MMP14 | P50281 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL298855 | 1.00 | CA12 (0.54) | CA12CA14CA2MMP2MMP9 | |
| SCHEMBL29367675 | 1.00 | CA12 (0.54) | CA12CA14CA2MMP2MMP9 | |
| SCHEMBL42287 | 1.00 | CA12 (0.54) | CA12CA14CA2MMP2MMP9 | |
| SCHEMBL29478385 | 1.00 | CA12 (0.54) | CA12CA14CA2MMP2MMP9 | |
| SCHEMBL42286 | 1.00 | CA12 (0.54) | CA12CA14CA2MMP2MMP9 | |
| Hydrochloric Acid SCHEMBL21433626 | 0.98 | CA12 (0.53) | CA12CA14CA2MMP2MMP9 | |
| Ammonia Solution, Strong SCHEMBL466944 | 0.98 | CA12 (0.53) | CA12CA14CA2MMP2MMP9 | |
| Hydrochloric Acid SCHEMBL21433625 | 0.98 | CA12 (0.53) | CA12CA14CA2MMP2MMP9 | |
| Ammonia Solution, Strong SCHEMBL466943 | 0.98 | CA12 (0.53) | CA12CA14CA2MMP2MMP9 | |
| Hydrochloric Acid SCHEMBL6420699 | 0.98 | CA12 (0.53) | CA12CA14CA2MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210030918-A1 | COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2021-02-04 | — | — | US | claimed |
| US-20170209845-A1 | FORMATION OF ORGANIC NANOSTRUCTURE ARRAY | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2017-07-27 | — | — | US | claimed |
| EP-2089418-B1 | FORMATION OF ORGANIC NANOSTRUCTURE ARRAY | UNIV RAMOT (IL) | 2016-11-09 | — | — | EP | claimed |
| EP-2961433-A1 | PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF | Ramot at Tel-Aviv University Ltd. (IL) | 2016-01-06 | — | — | EP | claimed |
| EP-1781310-B1 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | UNIV RAMOT (IL) | 2015-10-14 | — | — | EP | claimed |
| US-9074095-B2 | Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2015-07-07 | — | — | US | claimed |
| US-8927689-B2 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-01-06 | — | — | US | claimed |
| WO-2014132262-A1 | PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2014-09-04 | — | — | WO | claimed |
| US-8796023-B2 | Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2014-08-05 | — | — | US | claimed |
| US-20140027655-A1 | PEPTIDE NANOSTRUCTURES AND METHODS OF GENERATING AND USING THE SAME | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2014-01-30 | — | — | US | claimed |
| US-7504383-B2 | Peptide nanostructures encapsulating a foreign material and method of manufacturing same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-03-17 | — | — | US | claimed |
| US-7491699-B2 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL AVIV UNIVERSITY LTD. | 2009-02-17 | — | — | US | claimed |
| EP-1973928-A2 | SELF-ASSEMBLED FMOC-FF HYDROGELS | Ramot at Tel-Aviv University Ltd. (IL) | 2008-10-01 | — | — | EP | claimed |
| US-20080009434-A1 | at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2008-01-10 | — | — | US | claimed |
| EP-1781310-A2 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | Ramot at Tel Aviv University Ltd. (IL) | 2007-05-09 | — | — | EP | claimed |
| WO-2007043048-A2 | SELF-ASSEMBLED FMOC-FF HYDROGELS | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2007-04-19 | — | — | WO | claimed |
| US-20060079455-A1 | Peptide nanostructures encapsulating a foreign material and method of manufacturing same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-04-13 | — | — | US | claimed |
| US-20060079454-A1 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-04-13 | — | — | US | claimed |
| WO-2006027780-A2 | PEPTIDE NANOSTRUCTURES CONTAINING END-CAPPING MODIFIED PEPTIDES AND METHODS OF GENERATING AND USING THE SAME | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-03-16 | — | — | WO | claimed |
| WO-2006013552-A2 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-02-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210030918-A1 | COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION | VIP, NPPA, IAPP | CA12 900/4885CA14 414/4885CA2 2360/4885 |
| US-20080009434-A1 | at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody | DNPEP, LNPEP, ANPEP | CA12 402/4885CA14 294/4885CA2 641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.